Analysts at Robert W. Baird initiated coverage on shares of INmune Bio (NASDAQ:INMB – Get Rating) in a note issued to investors on Wednesday, The Fly reports. The firm set an “outperform” rating on the stock. INmune Bio Stock Down 3.7 % Shares of INMB traded down $0.29 during mid-day trading on Wednesday, reaching $7.58. […]
Analysts at Robert W. Baird initiated coverage on shares of INmune Bio (NASDAQ:INMB – Get Rating) in a note issued to investors on Wednesday, The Fly reports. The firm set an “outperform” rating on the stock. INmune Bio Stock Down 3.7 % Shares of INMB traded down $0.29 during mid-day trading on Wednesday, reaching $7.58. […]
INmune Bio (NASDAQ:INMB – Get Rating) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, May 3rd. Parties that are interested in participating in the company’s conference call can do so using this link. INmune Bio (NASDAQ:INMB – Get Rating) last released its quarterly earnings data on Thursday, March […]